Literature DB >> 6445896

Interaction of Escherichia coli adenosine triphosphatase with aurovertin and citreoviridin: inhibition and fluorescence studies.

M Satre, M Bof, P V Vignais.   

Abstract

Aurovertins B and D inhibited the adenosine triphosphatase (ATPase) activity of soluble Escherichia coli coupling factor ATPase (BF1) isolated from wile-type E. coli K-12. Half inhibition was obtained with 2 microns aurovertin B and 0.9 microns aurovertin D. Aurovertins B and D had no inhibitory effect on BF1 isolated from the aurovertin-resistant E. coli mutant MA12. Acetylation or saponification of aurovertin D yielded a derivative which was devoid of inhibitory effect on BF1. Citreoviridin also inhibited wild-type BF1 but with much less efficiency (half inhibition at 60 microns) than aurovertin. Citreoviridin had no effect on the aurovertin-resistant BF1. The fluorescence intensity of aurovertins B and D was markedly enhanced upon addition to purified BF1. There was no enhancement of fluorescence when the aurovertins were added to BF1 isolated from the aurovertin-resistant mutant. The fluorescence of the aurovertin-BF1 complex was enhanced by adenosine 5'-diphosphate and by low concentrations of adenosine 5'-triphosphate. The adenosine 5'-diphosphate-enhanced fluorescence of the aurovertin-BF1 complex was quenched by high concentrations of adenosine 5'-triphosphate or by MG2+. Aurovertin bound selectively to the beta subunit of BF1 isolated from wile-type cells. By complementation assays in vitro, using a reconstituted system made of subunits isolated from wild-type and aurovertin-resistant BF1, it was shown that the altered peptide in aurovertin-resistant BF1 was the beta subunit.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6445896      PMCID: PMC294092          DOI: 10.1128/jb.142.3.768-776.1980

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  33 in total

1.  Membrane-bound adenosine triphosphatase of Escherichia coli. I. Partial purification and properties.

Authors:  H Kobayashi; Y Anraku
Journal:  J Biochem       Date:  1972-03       Impact factor: 3.387

2.  The effect of aurovertin on a soluble mitochondrial adenosine triphosphatase.

Authors:  A M Roberton; R B Beechey; C T Holloway; I G Knight
Journal:  Biochem J       Date:  1967-09       Impact factor: 3.857

3.  Binding of aurovertin to phosphorylating submitochondrial particles.

Authors:  R J van de Stadt; K van Dam
Journal:  Biochim Biophys Acta       Date:  1974-05-22

4.  The use of the fluorescent probe aurovertin, to monitor energy linked conformational changes in mitochondrial ATPases.

Authors:  D Layton; A Azzi; P Graziotti
Journal:  FEBS Lett       Date:  1973-10-01       Impact factor: 4.124

5.  Energy-dependent enhancement of aurovertin fluorescence. An indicator of conformational changes in beef heart mitochondrial adenosine triphosphatase.

Authors:  T M Chang; H S Penefsky
Journal:  J Biol Chem       Date:  1974-02-25       Impact factor: 5.157

6.  The binding of aurovertin to mitochondria, and its effect on mitochondrial respiration.

Authors:  R M Bertina; P I Schrier; E C Slater
Journal:  Biochim Biophys Acta       Date:  1973-06-28

7.  The membrane ATPase of Escherichia coli. I. Ion dependence and ATP-ADP exchange reaction.

Authors:  M P Roisin; A Kepes
Journal:  Biochim Biophys Acta       Date:  1972-09-20

8.  Aurovertin, a fluorescent probe of conformational change in beef heart mitochondrial adenosine triphosphatase.

Authors:  T Chang; H S Penefsky
Journal:  J Biol Chem       Date:  1973-04-25       Impact factor: 5.157

9.  Oxidative phosphorylation in Escherichia coli K-12: the genetic and biochemical characterisations of a strain carrying a mutation in the uncB gene.

Authors:  J D Butlin; G B Cox; F Gibson
Journal:  Biochim Biophys Acta       Date:  1973-02-22

10.  Oxidative phosphorylation in Escherichia coli K12. Mutations affecting magnesium ion- or calcium ion-stimulated adenosine triphosphatase.

Authors:  J D Butlin; G B Cox; F Gibson
Journal:  Biochem J       Date:  1971-08       Impact factor: 3.857

View more
  10 in total

Review 1.  The ATP synthase (F0-F1) complex in oxidative phosphorylation.

Authors:  J P Issartel; A Dupuis; J Garin; J Lunardi; L Michel; P V Vignais
Journal:  Experientia       Date:  1992-04-15

Review 2.  Medicinal chemistry of ATP synthase: a potential drug target of dietary polyphenols and amphibian antimicrobial peptides.

Authors:  Zulfiqar Ahmad; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

3.  The stoichiometry of binding of the aurovertins to mitochondrial ATPases: revision of the molar absorption coefficient.

Authors:  P E Linnett; L J Mulheirn; R B Beechey
Journal:  J Bioenerg Biomembr       Date:  1983-04       Impact factor: 2.945

Review 4.  ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.

Authors:  Sangjin Hong; Peter L Pedersen
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

Review 5.  Natural products and other inhibitors of F1FO ATP synthase.

Authors:  Bhargav A Patel; Terin L D'Amico; Brian S J Blagg
Journal:  Eur J Med Chem       Date:  2020-09-03       Impact factor: 6.514

Review 6.  Recent developments on structural and functional aspects of the F1 sector of H+-linked ATPases.

Authors:  P V Vignais; M Satre
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

7.  Properties of F1-ATPase from the uncD412 mutant of Escherichia coli.

Authors:  J G Wise; T M Duncan; L R Latchney; D N Cox; A E Senior
Journal:  Biochem J       Date:  1983-11-01       Impact factor: 3.857

8.  Mechanistic basis for differential inhibition of the F1Fo-ATPase by aurovertin.

Authors:  Kathryn M Johnson; Lara Swenson; Anthony W Opipari; Rolf Reuter; Nawid Zarrabi; Carol A Fierke; Michael Börsch; Gary D Glick
Journal:  Biopolymers       Date:  2009-10       Impact factor: 2.505

9.  Quantitative proteomic analysis of human lung tumor xenografts treated with the ectopic ATP synthase inhibitor citreoviridin.

Authors:  Yi-Hsuan Wu; Chia-Wei Hu; Chih-Wei Chien; Yu-Ju Chen; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

10.  Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis.

Authors:  Myoung Sook Kim; Ramkishore Gernapudi; Yessenia Cedeño Cedeño; Brian M Polster; Ramon Martinez; Paul Shapiro; Santosh Kesari; Elmar Nurmemmedov; Antonino Passaniti
Journal:  Oncotarget       Date:  2020-10-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.